Addus HomeCare's (ADUS) Market Outperform Rating Reiterated at JMP Securities

JMP Securities restated their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS - Free Report) in a research note published on Wednesday morning,Benzinga reports. The firm currently has a $150.00 target price on the stock.

Other research analysts have also issued research reports about the stock. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Macquarie reiterated an "outperform" rating and issued a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Seven analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare currently has an average rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Price Performance

Shares of ADUS stock traded down $2.66 on Wednesday, reaching $107.03. The company had a trading volume of 136,336 shares, compared to its average volume of 166,386. The stock has a market capitalization of $1.97 billion, a PE ratio of 24.16, a price-to-earnings-growth ratio of 1.52 and a beta of 0.81. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. Addus HomeCare has a one year low of $88.96 and a one year high of $136.72. The business's 50-day moving average is $112.44 and its 200 day moving average is $110.01.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. The firm had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.21 earnings per share. Equities research analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president directly owned 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Natixis boosted its stake in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after purchasing an additional 132 shares during the period. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of Addus HomeCare during the first quarter valued at approximately $41,000. Meeder Asset Management Inc. purchased a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $77,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $86,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Addus HomeCare by 368.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock valued at $124,000 after purchasing an additional 987 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.